Gustave Bergnes - Concepedia

Author

Gustave Bergnes

Cytokinetics (United States)

Also Known As

G Bergnes, Gustave Bergnes

Publications

641

Citations

H-Index

Concepts

All Affiliations

Cytokinetics (United States)GlaxoSmithKline (United States)

About

Gustave Bergnes is an author at Cytokinetics (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	398
2	Natural Sciences	4	4	375
3	Biochemistry	3	3	70
4	Health Sciences	1	1	12
5	Biomolecular Engineering	1	1	64

Gustave Bergnes

Publications

452

Citations

H-Index

Page 1

	Year	Citations
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E Kenneth W. Wood, Latesh Lad, Lusong Luo, Proceedings of the National Academy of Sciences Antitumor ActivityCenp-e Motor ActivityMolecular BiologyCell DeathCytoskeleton	2010	252
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295 Xiangping Qian, Andrew McDonald, Han-Jie Zhou, ACS Medicinal Chemistry Letters Molecular BiologyNew GenerationCancer BiologyPharmaceutical ChemistryMedicinal Chemistry	2010	64
Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. Gustave Bergnes, Vrinda Khandekar, Margaret O'Keefe, PubMed Substrate AnalogsPharmacotherapyCreatine KinaseCancer BiologyTumor Biology	1996	30
Generation of an Ugi library of phosphate mimic-containing compounds and identification of novel dual specific phosphatase inhibitors Gustave Bergnes, Carla L. Gilliam, Michael D. Boisclair, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiosynthesisBioorganic ChemistryAldo-keto ReductaseBiochemistry	1999	29
Discovery of<i>Tirasemtiv</i>, the First Direct Fast Skeletal Muscle Troponin Activator Scott E. Collibee, Gustave Bergnes, Alexander R. Muci, ACS Medicinal Chemistry Letters	2018	29
Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function Scott E. Collibee, Gustave Bergnes, Chih-Yuan Chuang, Journal of Medicinal Chemistry	2021	25
A second generation KSP inhibitor, SB-743921, is a highly potent and active therapeutic in preclinical models of cancer Jeffrey R. Jackson, Aidan G. Gilmartin, Dash Dhanak, Active TherapeuticCell DeathCancer BiologyTumor BiologyReceptor Tyrosine Kinase	2006	12
Antifungal activity of a Candida albicans GGTase I inhibitor-Alanine conjugate. inhibition of Rho1p prenylation in C. albicans Krishna K. Murthi, Susan E. Smith, Arthur F. Kluge, Bioorganic & Medicinal Chemistry Letters Inhibitor-alanine ConjugateAntifungal AgentBiochemistryAntifungal ActivityAntifungal Agents	2003	11

Page 1